VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 49 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $311,968 | +110.0% | 42,794 | +70.6% | 0.00% | – |
| Q1 2024 | $148,527 | -40.8% | 25,089 | -61.1% | 0.00% | -100.0% |
| Q3 2023 | $250,808 | -37.3% | 64,558 | -6.9% | 0.00% | 0.0% |
| Q2 2023 | $400,196 | +30.7% | 69,358 | +47.3% | 0.00% | 0.0% |
| Q1 2023 | $306,105 | +119.0% | 47,093 | -7.3% | 0.00% | – |
| Q4 2022 | $139,755 | -2.3% | 50,820 | +3.9% | 0.00% | – |
| Q3 2022 | $143,000 | +37.5% | 48,893 | -9.9% | 0.00% | – |
| Q2 2022 | $104,000 | -43.5% | 54,267 | +232.6% | 0.00% | – |
| Q2 2021 | $184,000 | -7.1% | 16,316 | +24.5% | 0.00% | -100.0% |
| Q1 2021 | $198,000 | +2.1% | 13,100 | -26.1% | 0.00% | -50.0% |
| Q1 2020 | $194,000 | -70.5% | 17,729 | -57.1% | 0.00% | 0.0% |
| Q4 2019 | $657,000 | +133.0% | 41,345 | +138.1% | 0.00% | +100.0% |
| Q3 2018 | $282,000 | – | 17,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 62,882 | $512,000 | 1.42% |
| Diag Capital Management, LP | 114,947 | $937,000 | 1.07% |
| Perceptive Advisors | 3,410,412 | $27,794,000 | 1.06% |
| Fosun International Ltd | 794,279 | $6,473,000 | 0.39% |
| Orbimed Advisors | 1,479,733 | $12,060,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 63,916 | $521,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 97,000 | $791,000 | 0.09% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 327,420 | $2,668,000 | 0.05% |
| Capital Investment Advisory Services, LLC | 12,400 | $101,000 | 0.04% |
| CONNING INC. | 129,013 | $1,051,000 | 0.04% |